You are here: Industry Insights > KSM

News List

Government imports APIs worth Rs 28,529 crores in FY2020-21 expresspharma
August 05, 2021
The size of the API and Intermediates market in India is estimated to be Rs 96,000 crores in FY 2019-20.
Pharma industry appreciates modification in PLI scheme, seek more support expresspharma
November 02, 2020
The industry also raises concerns related to brownfield investments, protection of indigenous manufacturing.
Govt may allow 30 per cent import of chemicals/intermediates in PLI scheme expresspharma
July 22, 2020
In the next phase of the PLI scheme, the government has plans to incentivise excipient manufacturers.
Pharma cos should develop strategies to develop APIs and making India self-reliant: Dr Eswara Reddy expresspharma
June 28, 2020
Companies investing in backward integration, new age technology, etc. would get the preference in the PLI scheme.
Bulk drug manufacturers seek support from govt, regulatory authorities expresspharma
June 28, 2020
Indian bulk drug manufacturers have requested the government and regulating authorities to bring some changes in the existing policies along with regulatory reforms to uplift the country’s API industry and work towards Aatmanirbhar Bharat.
Strategic short term measures needed on the API front: Pharma experts expresspharma
June 19, 2020
Experts feel that a multi-pronged strategy comprising both, short term and long term measures, are crucial to deal with the fall out of the COVID-19 pandemic as well as mounting friction between India and China.
Pharma MSMEs ask government to extend incentives of PLI scheme expresspharma
June 15, 2020
Due to incremental sales and production provisions of the PLI scheme, the MSME sector is not able to avail the desired benefits.